Search results for "10.54"

showing 10 items of 59 documents

Endothelial GLP-1 (Glucagon-Like Peptide 1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension

2019

Supplemental Digital Content is available in the text.

0301 basic medicineMalemedicine.medical_specialtyhypertensionBlotting WesternInflammationBlood Pressure030204 cardiovascular system & hematologyangiotensin IImedicine.disease_causeGlucagon-Like Peptide-1 Receptor1005403 medical and health sciencesMice0302 clinical medicine10030Internal medicinemedicineoxidative stressAnimalsHypoglycemic AgentsReceptor10111Cells CulturedMice KnockoutliraglutideLiraglutidebusiness.industryBasic SciencesType 2 Diabetes MellitusEndothelial CellsAtherosclerosisGlucagon-like peptide-1Angiotensin II3. Good healthMice Inbred C57BLDisease Models Animal030104 developmental biologyEndocrinology10040inflammationComputingMethodologies_DOCUMENTANDTEXTPROCESSINGRNAmedicine.symptomCardiology and Cardiovascular Medicinebusiness10024Oxidative stressmedicine.drug
researchProduct

Meta-analysis of real-time fMRI neurofeedback studies using individual participant data: How is brain regulation mediated?

2015

An increasing number of studies using real-time fMRI neurofeedback have demonstrated that successful regulation of neural activity is possible in various brain regions. Since these studies focused on the regulated region(s), little is known about the target-independent mechanisms associated with neurofeedback-guided control of brain activation, i.e. the regulating network. While the specificity of the activation during self-regulation is an important factor, no study has effectively determined the network involved in self-regulation in general. In an effort to detect regions that are responsible for the act of brain regulation, we performed a post-hoc analysis of data involving different ta…

2805 Cognitive NeuroscienceVentrolateral prefrontal cortexBrain regulationCognitive NeuroscienceStress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]610 Medicine & healthCIBM-SPCddc:616.0757Brain mapping050105 experimental psychologyProcedural memory03 medical and health sciences0302 clinical medicineBasal gangliamedicineHumans0501 psychology and cognitive sciencesAnterior cingulate cortexBrain Mapping05 social sciencesBrainCognitionNeurofeedbackMagnetic Resonance Imagingmedicine.anatomical_structureNeurofeedback Real-time fMRI Brain regulationNeurology10054 Clinic for Psychiatry Psychotherapy and Psychosomatics2808 NeurologyMeta-analysisReal-time fMRINeurofeedbackPsychologyNeuroscience030217 neurology & neurosurgeryBrain Regulation ; Neurofeedback ; Real-time FmriNeuroImage
researchProduct

Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-cont…

2013

Background The catechol-O-methyltransferase (COMT) modulates dopaminergic neurotransmission in the prefrontal cortex as well as in the mesolimbic reward system. Since the reward system mediates addictive behavior, the COMT gene is a strong candidate gene regarding the pathophysiology of tobacco dependence and smoking behavior. Because of rather conflicting results in previous studies, the purpose of the present study was to test for association between a functional genetic variant in the COMT gene (single nucleotide polymorphism [SNP] rs4680) and tobacco smoking behavior. Methods In a population-based case-control multicenter study designed for tobacco addiction research, a total of 551 cur…

AdultCandidate genemedia_common.quotation_subjectPopulationEuropean Continental Ancestry Groupgenetics [Catechol O-Methyltransferase]Single-nucleotide polymorphism610 Medicine & healthCatechol O-MethyltransferasePolymorphism Single NucleotideWhite PeopleGermanymental disordersSNPMedicineHumanseducationmedia_commonGeneticseducation.field_of_studyCatechol-O-methyl transferasebusiness.industryAddictionSmokingPublic Health Environmental and Occupational Healthgenetics [Smoking]Tobacco Use Disorder2739 Public Health Environmental and Occupational HealthMiddle Agedmedicine.diseaseCase-Control Studies10054 Clinic for Psychiatry Psychotherapy and Psychosomaticsddc:640genetics [Tobacco Use Disorder]businessAddictive behaviorrs4680
researchProduct

Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women

2013

<b><i>Objective:</i></b> The neuropeptide-Y (NP-Y) gene is a strong candidate gene in the pathophysiology of obesity-linked behavior, and several single-nucleotide polymorphisms of NP-Y have already been linked to body weight and appetite. However, the results from current studies remain inconclusive. The aim of the present study was to test whether a certain functional genetic variant (SNP rs16147) in the NP-Y promoter gene is associated with serum leptin levels and body fat distribution. <b><i>Method:</i></b> We genotyped and measured the serum leptin levels of the NP-Y rs16147 polymorphism in 1,097 Caucasian subjects in the context of a pop…

AdultMaleLeptinCandidate genemedicine.medical_specialtyGenotypeblood [Leptin]Medicine (miscellaneous)610 Medicine & healthmacromolecular substancesPolymorphism Single NucleotideWhite PeopleStatistics NonparametricWaist–hip ratiogenetics [Obesity]Sex FactorsMedizinische FakultätInternal medicineGenotypemedicineHumansNeuropeptide YObesityddc:610Genephysiology [Neuropeptide Y]Nutrition and Dieteticsbusiness.industryWaist-Hip RatioLeptinCase-control study2701 Medicine (miscellaneous)Middle AgedNeuropeptide Y receptormedicine.diseaseObesitygenetics [European Continental Ancestry Group]EndocrinologyCase-Control Studies10054 Clinic for Psychiatry Psychotherapy and Psychosomatics2916 Nutrition and DieteticsFemalegenetics [Neuropeptide Y]businessphysiology [Polymorphism Single Nucleotide]
researchProduct

Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study

2020

Abstract Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study (COMPAS) was a prospective, randomized multicenter clinical trial, comparing methylphenidate (MPH) with placebo (PLAC) in combination with cognitive behavioral group psychotherapy (GPT) or individual clinical management (CM) over the period of 1 year. Here, we report results on treatment safety. Methods MPH and PLAC were flexibly dosed. Among 433 randomized patients, adverse events (AEs) were documented and analyzed on an “as received” basis during week 0–52. Electrocardiogram data were recorded at baseline and week 24. Results Comparing 205 patients who received ≥1 dose of MPH with 209 patients wh…

AdultMaleTachycardiamedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentMedizin610 Medicine & healthPlaceboGroup psychotherapyYoung Adult2738 Psychiatry and Mental Health03 medical and health sciences0302 clinical medicineDouble-Blind MethodInternal medicinemedicinePalpitationsHumans2736 Pharmacology (medical)Pharmacology (medical)Prospective StudiesAdverse effectCognitive Behavioral TherapyHyperhidrosisMethylphenidatebusiness.industryGeneral MedicineMiddle AgedCombined Modality Therapy3. Good health030227 psychiatryClinical trialPsychiatry and Mental healthAttention Deficit Disorder with Hyperactivity10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMethylphenidateCentral Nervous System StimulantsFemalePatient Safetymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugPharmacopsychiatry
researchProduct

Early detection of the risk of developing psychiatric disorders: a study of 461 Chinese university students under chronic stress

2019

Chronic stress, a characteristic of modern time, has a significant impact on general health. In the context of psychiatric disorders, insufficient coping behavior under chronic stress has been linked to higher rates of (1) depressive symptoms among subjects of the general population, (2) relapse among patients under treatment for clinical depression, and (3) negative symptoms among subjects with an elevated vulnerability to psychosis. In this normative study we assessed basic coping behavior among 461 Chinese freshman university students along with their consumption behavior and general health in terms of regular exercises, physical health, psychosomatic disturbances, and mental health. The…

AdultMalemedicine.medical_specialtyAdolescentUniversitiesPopulationEthnic groupNeural netsNormative dataContext (language use)610 Medicine & healthBasic coping behavior03 medical and health sciencesYoung Adult2738 Psychiatry and Mental Health0302 clinical medicineRisk FactorsmedicineHumanseducationPsychiatryStudentsSocioeconomic statusDepression (differential diagnoses)education.field_of_studyPrevention3203 Clinical PsychologyEarly detectionCollege/university studentsMental healthPsychophysiologic Disorders030227 psychiatryPsychotherapyPsychiatry and Mental healthClinical PsychologyEarly Diagnosis10072 Institute of Response Genetics10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsNormativeFemaleChronic stressMental healthPsychologyRisk assessmentPrediction030217 neurology & neurosurgeryStress PsychologicalResearch Article
researchProduct

Mitä mieltä, professorit?

2006

25 vuoden ikään ehtinyt Aikuiskasvatus kysyi kaikilta aikuiskasvatuksen professoreiltamme heidän näkemyksiään neljässä asiassa. Kaikkiin ei tarvinnut vastata. Tällaista kysyttiin ja näin vastasivat Yrjö Engeström ja Reijo Miettinen Helsingin yliopistosta, Anneli Eteläpelto Jyväskylän yliopistosta, Jukka Tuomisto ja Juha Suoranta Tampereen yliopistosta, Risto Rinne Turun yliopistosta, Kari E. Nurmi Lapin yliopistosta sekä vt:nä virkaa hoitava Leena Ahteenmäki-Pelkonen Joensuun yliopistosta. Vastausjärjestys on arvottu.

Ahteenmäki-Pelkonen LeenaEngeström Yrjökasvatustieteilijät [http://www.yso.fi/onto/yso/p20573]Rinne RistoMiettinen ReijoGeneral MedicineGeneral Chemistrytiede [http://www.yso.fi/onto/yso/p2240]Eteläpelto Annelitiedelehdet [http://www.yso.fi/onto/yso/p10315]Nurmi Kari E.Tuomisto JukkaSuoranta Juhatutkimus [http://www.yso.fi/onto/yso/p183]aikuiskoulutus [http://www.yso.fi/onto/yso/p300][Aikuiskasvatus]aikuiskasvatus [http://www.yso.fi/onto/yso/p10754]professorit [http://www.yso.fi/onto/yso/p17044]Aikuiskasvatus
researchProduct

"Table 1" of "Inclusive Lambda/c production in e+ e- annihilations at s**(1/2) = 10.54-GeV and in Upsilon(4S) decays."

2008

LAMBDA/C+ differential production rate per hadronic event for the continuum at cm energy 10.54 GeV.

DN/DXInclusive10.54Strange productionE+ E- ScatteringE+ E- --> LAMBDA/C+ XHigh Energy Physics::ExperimentUpsilonSingle Differential DistributionNuclear Experiment
researchProduct

"Table 3" of "Inclusive Lambda/c production in e+ e- annihilations at s**(1/2) = 10.54-GeV and in Upsilon(4S) decays."

2008

LAMBDA/C+ differential production rate per UPSILON(4S) decay at cm energy 10.58 GeV.

DN/DXInclusiveE+ E- --> UPSILON(4S) X10.54Strange productionE+ E- ScatteringE+ E- --> LAMBDA/C+ XHigh Energy Physics::ExperimentUpsilonSingle Differential DistributionNuclear Experiment
researchProduct

"Table 1" of "Measurement of the e+ e- ---> b anti-b cross section between s**(1/2) = 10.54-GeV and 11.20-GeV"

2008

Measured values of R(b) from the detailed scan in SQRT(S),. where R(b) is the ratio between the number of observed E+ E- --> B BBAR(GAMMA) normalized to luminosity divided to the bare dimuon cross-section.

E+ E- --> BQ BQBAR (GAMMA)E+ E- ScatteringIntegrated Cross Section10.541-11.206ExclusiveCross SectionSIG
researchProduct